Stifel Initiates Coverage On SpyGlass Pharma with Buy Rating, Announces Price Target of $42

SpyGlass Pharma, Inc. +0.06%

SpyGlass Pharma, Inc.

SGP

26.84

+0.06%

Stifel analyst Tom Stephan initiates coverage on SpyGlass Pharma (NASDAQ: SGP) with a Buy rating and announces Price Target of $42.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via